Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for histone deacetylase inhibitor (compound)
Most Correlated Studies
- Embryonic and trophoblast stem cells treated with Trichostatin A
- Pancreatic cell lines treated with chromatin-targeting small molecules
- Neurospheres cultured from embryonic striatum and treated with BMP2 or trichostatin A
- Pre-cursor B cell acute lymphoblastic leukemia cells and patient samples treated with vorinostat
- CD4-positive T cells from healthy donors treated with suberoylanilide hydroxamic acid
Most Relevant Literature
- Histone deacetylase (HDACs) inhibitors: Clinical applications.
- An updated patent review of histone deacetylase (HDAC) inhibitors in cancer (2020 - present).
- NO-HDAC dual inhibitors.
- HDAC inhibitors: Promising agents for leukemia treatment.
- Multi-targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective.
Most Relevant Clinical Trials
- Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherap…
- Dietary Histone Deacetylase Inhibitors (HDAC)
- Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours
- Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Ca…
- Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone De…
